The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Soshil Kumar Jain
Panacea Biotec: Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
01-Apr-2018
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month